Jul. 8 at 8:29 PM
$BEAM Based on 14 Wall Street analysts offering 12 month price targets for Beam Therapeutics in the last 3 months. The average price target is
$44.58 with a high forecast of
$80.00 and a low forecast of
$20.00. The average price target represents a 124.25% change from the last price of
$19.88.
